Literature DB >> 12956831

Depression and subjective quality of life in chronic phase schizophrenic patients.

G Reine1, C Lançon, S Di Tucci, C Sapin, P Auquier.   

Abstract

OBJECTIVE: To evaluate the influence of depression on subjective quality of life in schizophrenic patients.
METHOD: Sixty-seven schizophrenic patients in a stabilized phase were included. Schizophrenic symptoms were evaluated using the Positive and Negative Symptoms Scale (PANSS). The subjective quality of life was evaluated using the short version of the Lehman quality of life scale (QoLI). Depression was evaluated using the Calgary Depression Scale for Schizophrenia (CDSS) and extrapyramidal effects with the Extrapyramidal Symptoms Rating Scale (ESRS).
RESULTS: The PANSS total score, PANSS general psychopathology subscore, PANSS depression factor, the total CDSS and some ESRS scores were negatively correlated with the overall life satisfaction score. The CDSS score was negatively correlated with all except one QoLI score. QoLI scores were significantly lower in depressed patients, and this result remained consistent for four QoLi dimensions when adjusted on ESRS and PANSS scores. When analysing the association between high depression scores and high parkinsonism scores with reduced quality of life, multivariate analysis showed that depression was the main explanatory factor: the CDSS total score explained 22% of the variance of the overall subjective quality of life score. The patient questionnaire at the ESRS explained 10.5% of the variance of the 'mental and physical health' QoLI score.
CONCLUSION: In schizophrenic patients, depressive symptoms should be focused because of their strong association to overall subjective quality of life.

Entities:  

Mesh:

Year:  2003        PMID: 12956831     DOI: 10.1034/j.1600-0447.2003.00132.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  20 in total

1.  A dual change model of life satisfaction and functioning for individuals with schizophrenia.

Authors:  Melissa Edmondson; Rohini Pahwa; Karen Kyeunghae Lee; Maanse Hoe; John S Brekke
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

2.  The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.

Authors:  Robert R Conley; Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Bruce J Kinon
Journal:  Schizophr Res       Date:  2006-11-15       Impact factor: 4.939

3.  Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.

Authors:  Shaun M Eack; Christina E Newhill
Journal:  Schizophr Bull       Date:  2007-01-04       Impact factor: 9.306

4.  The quality of life of the mentally ill living in residential facilities: findings from a national survey in Italy.

Authors:  Angelo Picardi; Paola Rucci; Giovanni de Girolamo; Giovanni Santone; Gabriele Borsetti; Pierluigi Morosini
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

5.  Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.

Authors:  Shinichiro Nakajima; Hiroyoshi Takeuchi; Gagan Fervaha; Eric Plitman; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Yukiko Mihashi; Philip Gerretsen; Gary Remington; Benoit Mulsant; Ariel Graff-Guerrero
Journal:  Schizophr Res       Date:  2014-12-30       Impact factor: 4.939

6.  Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study.

Authors:  Dinesh Mittal; Richard R Owen; Jonathan P Lacro; Pharm D; Reid D Landes; Mark Edlund; Marcia Valenstein; Dilip V Jeste
Journal:  Clin Schizophr Relat Psychoses       Date:  2009-01-01

7.  Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?

Authors:  Sofia Brissos; Vicent Balanzá-Martinez; Vasco Videira Dias; Ana Isabel Carita; Maria Luisa Figueira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-08       Impact factor: 5.270

8.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

9.  Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.

Authors:  Adesanmi Akinsulore; Olutayo O Aloba; B M Mapayi; I O Oloniniyi; F O Fatoye; R O A Makanjuola
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

10.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.